Format

Send to

Choose Destination
See comment in PubMed Commons below
J Chromatogr B Analyt Technol Biomed Life Sci. 2013 Dec 15;941:81-9. doi: 10.1016/j.jchromb.2013.10.009. Epub 2013 Oct 15.

Analysis of free, mono- and diacetylated polyamines from human urine by LC-MS/MS.

Author information

  • 1School of Pharmacy, Biocenter Kuopio, University of Eastern Finland, Kuopio, Finland. Electronic address: Merja.Hakkinen@uef.fi.

Abstract

Polyamines are promising biochemical markers of cancer and many other pathophysiological conditions, and thus their concentrations in biological fluids are a matter of interest. However, since the concentrations of these compounds are low, their quantitation is typically based on methods requiring laborious sample preparation. Here we developed and validated an LC-MS/MS method to analyze simultaneously free (DAP, PUT, CAD, SPD, SPM) monoacetylated (AcPUT, AcCAD, N(1)AcSPD, N(8)AcSPD, N(1)AcSPM) and diacetylated (DiAcPUT, DiAcCAD, DiAcSPD, DiAcSPM) polyamines from human urine without the need for derivatization. Deuterium labeled polyamines were the internal standards for each analyte. Diluted urine samples spiked with internal standards were filtered through a strong anion exchange resin prior to LC-MS/MS analysis. The chromatographic separation of 14 polyamines was achieved in 12min on C18 column with 0.1% HFBA (v/v) as the ion-pairing agent and a water-acetonitrile gradient. Ionization was performed with positive electrospray ionization (ESI) and detection was with a triple quadrupole mass spectrometer with selected reaction monitoring. Calibration curves ranged from up to 5 to 10,000nM. The accuracy and precision of the method were determined using urine based quality control samples, and matrix effects were examined by using standard addition methods. This novel method is suitable for elucidating differences in urinary polyamine excretion in cancer patients and healthy humans.

KEYWORDS:

AcCAD; AcPUT; CAD; Cancer diagnostic markers; DAP; DiAcCAD; DiAcPUT; DiAcSPD; DiAcSPM; Liquid chromatography–tandem mass spectrometry; N(1)-(3-aminopropyl)butane-1,4-diamine trihydrochloride; N(1)AcSPD; N(1)AcSPM; N(8)AcSPD; N,N′-((butane-1,4-diylbis(azanediyl))bis(propane-3,1-diyl))diacetamide dihydrochloride; N,N′-(butane-1,4-diyl)diacetamide; N,N′-(pentane-1,5-diyl)diacetamide; N,N′-bis-(3-aminopropyl)butane-1,4-diamine tetrahydrochloride; N-(3-((4-((3-aminopropyl)amino)butyl)amino)propyl)acetamide trihydrochloride; N-(3-((4-acetamidobutyl)amino)propyl)acetamide hydrochloride; N-(3-((4-aminobutyl)amino)propyl)acetamide dihydrochloride; N-(4-((3-aminopropyl)amino)butyl)acetamide dihydrochloride; N-(4-aminobutyl)acetamide hydrochloride; N-(5-aminopentyl)acetamide hydrochloride; N-acetylated; PUT; Polyamines; Prostate cancer; SPD; SPM; Urine; butane-1,4-diamine dihydrochloride; pentane-1,5-diamine dihydrochloride; propane-1,3-diamine dihydrochloride

PMID:
24185098
DOI:
10.1016/j.jchromb.2013.10.009
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center